We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review

Published: April 2019
Pages: 56
Code: 1FBB2CA57393127FA70FC4DAAF034428
Format: PDF
Publisher GlobalData
From Add to basket
$ 125.00
Provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Additonal Information

  • - Business description – A detailed description of the company’s operations and business divisions.
  • - Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • - Company history – Progression of key events associated with the company.
  • - Major products and services – A list of major products, services and brands of the company.
  • - Key competitors – A list of key competitors to the company.
  • - Key employees – A list of the key executives of the company.
  • - Executive biographies – A brief summary of the executives’ employment history.
  • - Key operational heads – A list of personnel heading key departments/functions.
  • - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • - Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
  • Highlights
  • Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. The company offers its products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Pacific Rim, among others. Bio-Rad is headquartered in Hercules, California, the US.
  • Bio-Rad Laboratories Inc Key Recent Developments
  • Apr 02,2019 Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
  • Feb 28,2019 Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
  • Feb 14,2019 2/15/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
  • Feb 14,2019 2/21/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.

Companies Mentioned

Tosoh Corp
Thermo Fisher Scientific Inc
Siemens Healthineers AG
Roche Diagnostics International Ltd
Ortho-Clinical Diagnostics Inc
Immucor Inc
GE Biosciences
Diasorin SA
Danaher Corp
bioMerieux SA
Becton Dickinson and Co

Reasons to buy

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company
Add to basket
  • Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Section 1 - About the Company
  • Bio-Rad Laboratories Inc - Key Facts
  • Bio-Rad Laboratories Inc - Key Employees
  • Bio-Rad Laboratories Inc - Key Employee Biographies
  • Bio-Rad Laboratories Inc - Major Products and Services
  • Bio-Rad Laboratories Inc - History
  • Bio-Rad Laboratories Inc - Company Statement
  • Bio-Rad Laboratories Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 – Company Analysis
  • Company Overview
  • Bio-Rad Laboratories Inc - Business Description
  • Business Segment: Clinical Diagnostics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Life Science
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: Pacific Rim
  • Performance
  • Geographical Segment: United States
  • Performance
  • Bio-Rad Laboratories Inc - Corporate Strategy
  • Bio-Rad Laboratories Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Bio-Rad Laboratories Inc - Strengths
  • Bio-Rad Laboratories Inc - Weaknesses
  • Bio-Rad Laboratories Inc - Opportunities
  • Bio-Rad Laboratories Inc - Threats
  • Bio-Rad Laboratories Inc - Key Competitors
  • Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Bio-Rad Laboratories Inc, Recent Deals Summary
  • Section 5 – Company’s Recent Developments
  • Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
  • Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
  • Feb 14, 2019: 2/15/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
  • Feb 14, 2019: 2/21/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.
  • Feb 01, 2019: Bio-Rad showcases new automation features of its ZE5 cell analyzer at SLAS 2019
  • Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
  • Dec 03, 2018: Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease
  • Dec 03, 2018: Bio-Rad quality controls now available for multiple Abbott clinical diagnostics platforms
  • Nov 14, 2018: Bio-Rad and the University of Chicago win patent infringement case against 10X Genomics related to droplet microfluidics technologies
  • Nov 01, 2018: Bio-Rad reports third-quarter 2018 financial results
  • Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • List of Tables
  • Bio-Rad Laboratories Inc, Key Facts
  • Bio-Rad Laboratories Inc, Key Employees
  • Bio-Rad Laboratories Inc, Key Employee Biographies
  • Bio-Rad Laboratories Inc, Major Products and Services
  • Bio-Rad Laboratories Inc, History
  • Bio-Rad Laboratories Inc, Subsidiaries
  • Bio-Rad Laboratories Inc, Key Competitors
  • Bio-Rad Laboratories Inc, Ratios based on current share price
  • Bio-Rad Laboratories Inc, Annual Ratios
  • Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
  • Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
  • Bio-Rad Laboratories Inc, Interim Ratios
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Bio-Rad Laboratories Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Bio-Rad Laboratories Inc, Performance Chart (2014 - 2018)
  • Bio-Rad Laboratories Inc, Ratio Charts
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

Keywords
;